Merck & Co Inc.

Sections

RSSNews (1021)

1. November 2, 2012 FTC Likely To Get New Chairman After Election
2. November 2, 2012 DOJ Wants Teva Docs In Connection With FCPA Investigation
3. November 1, 2012 Merck Puts Up $39M To Settle Vioxx Class Action
4. November 1, 2012 Markey Rolls Out Reform Bill In Wake Of Meningitis Outbreak
5. October 29, 2012 NJ Judge Won't Reconsider Tossing Shareholder's Vioxx Suit
6. October 26, 2012 Merck Can't Shield Testimony Docs In NuvaRing MDL
7. October 25, 2012 Pfizer, Ranbaxy Can't Pause Lipitor Pay-For-Delay Suit
8. October 24, 2012 GSK, Teva Can't Put Brakes On Pay-For-Delay Challenge
9. October 19, 2012 LA Plaintiffs Firm AlderLaw Sets Up Shop In Orange County
10. October 15, 2012 Innovative Managing Partner: Goldman Ismail's Melissa Widen
11. October 9, 2012 Merck Ordered To Turn Over Docs In Vioxx MDL
12. October 9, 2012 Sanofi, Merck JV Recalls Faulty Typhoid Vaccine, UK Says
13. October 5, 2012 FTC’s Androgel Case May Not Be Best To Tackle Pay-For-Delay
14. October 4, 2012 FTC Takes Androgel Pay-For-Delay Case To High Court
15. October 3, 2012 Generics Group Urges High Court To Take Pay-For-Delay Case
16. October 2, 2012 Merck Sues To Block Sandoz's Generic Zetia
17. September 27, 2012 Whistleblowers Behind Texas' High Fraud Settlement Recovery
18. September 26, 2012 Merck Investors Win Class Cert. In 2 Suits Over Vytorin
19. September 25, 2012 Bayer, Others Ask High Court To Review Pay-For-Delay Case
20. September 25, 2012 9th Circ. Affirms Merck's Win In Vaccine Wrongful Death Suit